Abstract
BackgroundPositive anti-melanoma differentiation-associated gene 5 (MDA5) antibody has been reported in 50%–73% of patients with clinical amyopathic dermatomyositis (CADM)1. About half of MDA5 +CADM patients die of rapid progressive interstitial...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
